Anders Bjartell
131 – 140 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
- Contribution to journal › Article
-
Mark
A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
- Contribution to journal › Article
-
Mark
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- Contribution to journal › Article
- 2018
-
Mark
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model : An Individual Patient Data Meta-Analysis
- Contribution to journal › Article
-
Mark
A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
- Contribution to journal › Article
-
Mark
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
- Contribution to journal › Article
-
Mark
Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy : Results from the LAParoscopic Prostatectomy Robot Open Trial
- Contribution to journal › Article
-
Mark
Generalization of prostate cancer classification for multiple sites using deep learning
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Social constraints and psychological well-being after prostate cancer : A follow-up at 12 and 24 months after surgery
- Contribution to journal › Article
